drug development
- Technology
Waters Peptide Multi-Attribute Method for BioAccord System Boosts Innovator and Biosimilar Drug Development and Commercialization
Milford, Mass., United States: NEWS SUMMARY: New Peptide MAM (multi-attribute method) workflow for the BioAccord LC-MS System monitors product quality…
Read More » - United States
Wellcome Sanger Institute Selects Arima Genomics as HiC Technology Partner; Company Announces Early Access Program for high-coverage HiC
San Diego, United States: Arima Genomics, Inc., a biotechnology company accelerating the adoption of the genome structure information, announced today…
Read More »